ALNY. Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia
– Genzyme to Advance ALN-TTR02 and ALN-TTRsc Programs as Breakthrough Therapies for Patients with ATTR in Japan and in the Broader Asian Market –
– Alnylam to Receive $22.5 Million in Upfront Payment in Addition to Milestone Payments and Royalties on Product Sales; Alnylam Maintains All Rights in U.S., Europe, and Rest of World –
http://finance.yahoo.com/news/alnylam-genzyme-form-alliance-develop-100000269.html
– Genzyme to Advance ALN-TTR02 and ALN-TTRsc Programs as Breakthrough Therapies for Patients with ATTR in Japan and in the Broader Asian Market –
– Alnylam to Receive $22.5 Million in Upfront Payment in Addition to Milestone Payments and Royalties on Product Sales; Alnylam Maintains All Rights in U.S., Europe, and Rest of World –
http://finance.yahoo.com/news/alnylam-genzyme-form-alliance-develop-100000269.html
Index Prime
http://investorshub.advfn.com/Index-Prime-25623/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
